David was previously the VP of Transformation at Aetna where he oversaw the member-facing capabilities for the enterprise. These areas included Aetna’s digital assets, concierge services, Apple partnership, high-touch clinical services as well as business units in healthcare payments, benefits enrollment and population health management.
Prior to joining Aetna, David was the Head of Biotech at PPD, a global clinical research organization. David began his career at Morgan Stanley and then Hellman & Friedman, a large private equity firm, where he focused on healthcare investing.
David was a Morehead Scholar at the University of North Carolina and holds an MBA from Harvard Business School.